The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Early Detection of Cancer: Past, Present, and Future
Abstract
Screening in both healthy and high-risk populations offers the opportunity to detect cancer early and with an increased opportunity for treatment and curative intent. Currently, a defined role for screening exists in some cancer types, but each screening test has limitations, and improved screening methods are urgently needed. Unfortunately, many cancers still lack effective screening recommendations, or in some cases, the benefits from screening are marginal when weighed against the potential for harm. Here we review the current status of cancer screening: we examine the role of traditional tumor biomarkers, describe recommended imaging for early tumor surveillance, and explore the potential of promising novel cancer markers such as circulating tumor cells (CTC) and circulating tumor DNA. Consistent challenges for all of these screening tests include limited sensitivity and specificity. The risk for overdiagnosis remains a particular concern in screening, whereby lesions of no clinical consequence may be detected and thus create difficult management decisions for the clinician and patient. If treatment is pursued following overdiagnosis, patients may be exposed to morbidity from a treatment that may not provide any true benefit. The cost-effectiveness of screening tests also needs to be an ongoing focus. The improvement of genomic and surveillance technologies, which leads to more precise imaging and the ability to characterize blood-based tumor markers of greater specificity, offers opportunities for major progress in cancer screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citationCirculating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Harper, D. M., Kemper, A. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.5989 · Cited by 2,509
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,959
Lieberman, D. A., Rex, D. K., Winawer, S. J., Giardiello, F. M., Johnson, D. A., & Levin, T. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.001 · Cited by 1,892
Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., Dekernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35233-3 · Cited by 1,592
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214726 · Cited by 1,414
Association of Colonoscopy and Death From Colorectal Cancer
Baxter, N. N., Goldwasser, M. A., Paszat, L. F., Saskin, R., Urbach, D. R., & Rabeneck, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00306 · Cited by 1,254
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Bach, P. B., Mirkin, J. N., Oliver, T. K., Azzoli, C. G., Berry, D. A., Brawley, O. W., Byers, T., Colditz, G. A., Gould, M. K., Jett, J. R., et al. (2012) · JAMA · doi:10.1001/jama.2012.5521 · Cited by 1,244
Winawer, S. J., Zauber, A. G., O'Brien, M. J., Ho, M. N., Gottlieb, L., Sternberg, S. S., Waye, J. D., Bond, J., Schapiro, M., Stewart, E. T., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304013281301 · Cited by 971
Protection From Colorectal Cancer After Colonoscopy: A Population-Based, Case–Control Study
Brenner, H., Chang-Claude, J., Seiler, C. M., Rickert, A., & Hoffmeister, M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-1-201101040-00004 · Cited by 773
American Cancer Society lung cancer screening guidelines
Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., Etzioni, R., Flowers, C. R., Scott Gazelle, G., Kelsey, D. K., et al. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21172 · Cited by 723
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Jaklitsch, M. T., Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., MacMahon, H., Mulshine, J. L., Munden, R. F., Salgia, R., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.05.060 · Cited by 608
Results of the Two Incidence Screenings in the National Lung Screening Trial
Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., Fagerstrom, R. M., Gareen, I. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208962 · Cited by 550
Cost-Effectiveness of CT Screening in the National Lung Screening Trial
Black, W. C., Gareen, I. F., Soneji, S. S., Sicks, J. D., Keeler, E. B., Aberle, D. R., Naeim, A., Church, T. R., Silvestri, G. A., Gorelick, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312547 · Cited by 544
A Dictionary of Epidemiology (DRAFT)
(2014) · doi:10.1093/acref/9780199976720.001.0001 · Cited by 530
The Reduction in Colorectal Cancer Mortality After Colonoscopy Varies by Site of the Cancer
Singh, H., Nugent, Z., Demers, A. A., Kliewer, E. V., Mahmud, S. M., & Bernstein, C. N. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.052 · Cited by 482
Warner, E., Plewes, D. B., Shumak, R. S., Catzavelos, G. C., Di Prospero, L. S., Yaffe, M. J., Goel, V., Ramsay, E., Chart, P. L., Cole, D. E. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3524 · Cited by 461
A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions
Pace, L. E., & Keating, N. L. (2014) · JAMA · doi:10.1001/jama.2014.1398 · Cited by 461
Smith, R. A., Manassaram‐Baptiste, D., Brooks, D., Doroshenk, M., Fedewa, S., Saslow, D., Brawley, O. W., & Wender, R. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21261 · Cited by 451
Pastorino, U., Rossi, M., Rosato, V., Marchianò, A., Sverzellati, N., Morosi, C., Fabbri, A., Galeone, C., Negri, E., Sozzi, G., et al. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328351e1b6 · Cited by 414
Detterbeck, F. C., Mazzone, P. J., Naidich, D. P., & Bach, P. B. (2013) · Chest · doi:10.1378/chest.12-2350 · Cited by 411
Saghir, Z., Dirksen, A., Ashraf, H., Bach, K. S., Brodersen, J., Clementsen, P. F., Døssing, M., Hansen, H., Kofoed, K. F., Larsen, K. R., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200736 · Cited by 390
Horeweg, N., Scholten, E. T., de Jong, P. A., van der Aalst, C. M., Weenink, C., Lammers, J.-W. J., Nackaerts, K., Vliegenthart, R., ten Haaf, K., Yousaf-Khan, U. A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70387-0 · Cited by 384
Infante, M., Cavuto, S., Lutman, F. R., Brambilla, G., Chiesa, G., Ceresoli, G., Passera, E., Angeli, E., Chiarenza, M., Aranzulla, G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0076oc · Cited by 379
Baxter, N. N., Warren, J. L., Barrett, M. J., Stukel, T. A., & Doria-Rose, V. P. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.4772 · Cited by 347
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I.-M., Kurman, R., Dao, F., Levine, D. A., Giuntoli, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004952 · Cited by 327
Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups
John, E. M., Miron, A., Gong, G., Phipps, A. I., Felberg, A., Li, F. P., West, D. W., & Whittemore, A. S. (2007) · JAMA · doi:10.1001/jama.298.24.2869 · Cited by 327
Hofman, V., Ilie, M. I., Long, E., Selva, E., Bonnetaud, C., Molina, T., Vénissac, N., Mouroux, J., Vielh, P., & Hofman, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25819 · Cited by 304
Samadder, N. J., Curtin, K., Tuohy, T. M. F., Pappas, L., Boucher, K., Provenzale, D., Rowe, K. G., Mineau, G. P., Smith, K., Pimentel, R., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.013 · Cited by 285
Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers
Kurian, A. W., Sigal, B. M., & Plevritis, S. K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7991 · Cited by 242
Pijpe, A., Andrieu, N., Easton, D. F., Kesminiene, A., Cardis, E., Nogues, C., Gauthier-Villars, M., Lasset, C., Fricker, J.-P., Peock, S., et al. (2012) · BMJ · doi:10.1136/bmj.e5660 · Cited by 230
Becker, N., Motsch, E., Gross, M.-L., Eigentopf, A., Heussel, C. P., Dienemann, H., Schnabel, P. A., Pilz, L., Eichinger, M., Optazaite, D.-E., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1228-9 · Cited by 190
Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer
Franken, B., de Groot, M. R., Mastboom, W. J., Vermes, I., van der Palen, J., Tibbe, A. G., & Terstappen, L. W. (2012) · Breast Cancer Research · doi:10.1186/bcr3333 · Cited by 189
Rijnsburger, A. J., Obdeijn, I.-M., Kaas, R., Tilanus-Linthorst, M. M. A., Boetes, C., Loo, C. E., Wasser, M. N. J. M., Bergers, E., Kok, T., Muller, S. H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2294 · Cited by 183
Ilié, M., Hofman, V., Long-Mira, É., Bordone, O., Selva, É., Washetine, K., Marquette, C., & Hofman, V. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.08.11 · Cited by 175
Modern mammography screening and breast cancer mortality: population study
Weedon‐Fekjær, H., Romundstad, P., & VATTEN, L. J. (2014) · BMJ · doi:10.1136/bmj.g3701 · Cited by 161
Aberle, D. R., Abtin, F. G., & Brown, K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.3110 · Cited by 159
Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening
Croswell, J. M., Baker, S. G., Marcus, P. M., Clapp, J. D., & Kramer, B. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-8-201004200-00007 · Cited by 156
Basch, E., Oliver, T. K., Vickers, A. J., Thompson, I. M., Kantoff, P. W., Parnes, H. L., Loblaw, D. A., Roth, B. J., Williams, J. K., & Nam, R. K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.3441 · Cited by 156
Long-Term Risk of Colorectal Cancer After Negative Colonoscopy
Brenner, H., Chang-Claude, J. C., Seiler, C. M., & Hoffmeister, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9307 · Cited by 153
Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial
Pegna, A. L., Picozzi, G., Falaschi, F., Carrozzi, L., Falchini, M., Carozzi, F., Pistelli, F., Comin, C., Deliperi, A., Grazzini, M., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828f68d6 · Cited by 144
Low Risk of Colorectal Cancer and Advanced Adenomas More Than 10 Years After Negative Colonoscopy
Brenner, H., Haug, U., Arndt, V., Stegmaier, C., Altenhofen, L., & Hoffmeister, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.10.054 · Cited by 143
Burt, R. W., Cannon, J. A., David, D. S., Early, D. S., Ford, J. M., Giardiello, F. M., Halverson, A. L., Hamilton, S. R., Hampel, H., Ismail, M. K., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0180 · Cited by 139
Lowry, K. P., Lee, J. M., Kong, C. Y., McMahon, P. M., Gilmore, M. E., Chubiz, J. E. C., Pisano, E. D., Gatsonis, C. A., Ryan, P. D., Ozanne, E. M., et al. (2011) · Cancer · doi:10.1002/cncr.26424 · Cited by 134
Circulating tumour cells—monitoring treatment response in prostate cancer
Miyamoto, D. T., Sequist, L. V. D., & Lee, R. J. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.82 · Cited by 130
Goulart, B. H. L., Bensink, M. E., Mummy, D. G., & Ramsey, S. D. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0023 · Cited by 128
Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer
Sotelo, M. J., Sastre, J., Maestro, M. L., Veganzones, S., Viéitez, J. M., Alonso, V., Grávalos, C., Escudero, P., Vera, R., Aranda, E., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu568 · Cited by 81
Gilbert, F. J., Warren, R. M. L., Kwan-Lim, G. E., Thompson, D. J., Eeles, R. A., Evans, D. G., Leach, M. O., & For the United Kingdom Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group (2009) · Radiology · doi:10.1148/radiol.2522081032 · Cited by 75
Huang, X., Gao, P., Song, Y., Sun, J., Chen, X., Zhao, J., Liu, J., Xu, H., & Wang, Z. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-976 · Cited by 74
Hereditary and Common Familial Colorectal Cancer: Evidence for Colorectal Screening
Samadder, N. J., Jasperson, K. W., & Burt, R. W. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3465-z · Cited by 70
Screening and early detection efforts in lung cancer
Kanodra, N. M., Silvestri, G. A., & Tanner, N. T. (2015) · Cancer · doi:10.1002/cncr.29222 · Cited by 67
Exposure to colorectal examinations before a colorectal cancer diagnosis: a case–control study
Mulder, S. A., van Soest, E. M., Dieleman, J. P., van Rossum, L. G. M., Ouwendijk, R. J. T., van Leerdam, M. E., & Kuipers, E. J. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328333fc6a · Cited by 54
Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors
Ramsey, S. D., Henry, N. L., Gralow, J. R., Mirick, D. K., Barlow, W. E., Etzioni, R., Mummy, D. G., Thariani, R., & Veenstra, D. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5409 · Cited by 54
Screening and surveillance for colorectal cancer: state of the art
Kahi, C. J., Anderson, J. C., & Rex, D. K. (2013) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.01.002 · Cited by 50
Physicians’ Beliefs About Breast Cancer Surveillance Testing are Consistent With Test Overuse
Han, P. K. J., Klabunde, C. N., Noone, A., Earle, C. C., Ayanian, J. Z., Ganz, P. A., Virgo, K. S., & Potosky, A. L. (2012) · Medical Care · doi:10.1097/mlr.0b013e31827da908 · Cited by 42
Rescreening of Persons With a Negative Colonoscopy Result: Results From a Microsimulation Model
Knudsen, A. B., Hur, C., Gazelle, G. S., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-9-201211060-00005 · Cited by 29
Breast Cancer Surveillance in Women with Hereditary Risk Due to BRCA1 or BRCA2 Mutations
Robson, M. E. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.029 · Cited by 29
Elmore, J. G., & Kramer, B. S. (2014) · JAMA · doi:10.1001/jama.2014.2494 · Cited by 27
Lung Cancer Screening, Radiation, Risks, Benefits, and Uncertainty
O’Connor, G. T., & Hatabu, H. (2012) · JAMA · doi:10.1001/jama.2012.6096 · Cited by 23
Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
Tie, J., Kinde, I., Wang, Y., Wong, H., Skinner, I., Wong, R., Steel, M., Diaz, L. A., Papadopoulos, N., Kosmider, S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.11015 · Cited by 19
Self-citation
Cited by
Breath Sensors for Health Monitoring
Güntner, A. T., Abegg, S., Königstein, K., Gerber, P. A., Schmidt-Trucksäss, A., & Pratsinis, S. E. (2019) · ACS Sensors · doi:10.1021/acssensors.8b00937 · Cited by 410
Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
Shin, H., Choi, B. H., Shim, O., Kim, J., Park, Y., Cho, S. K., Kim, H. K., & Choi, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-37403-1 · Cited by 402
Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
Wang, S., Zhang, K., Tan, S., Xin, J., Yuan, Q., Xu, H., Xu, X., Liang, Q., Christiani, D. C., Wang, M., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01298-z · Cited by 331
Biosensing based on field-effect transistors (FET): Recent progress and challenges
Sadighbayan, D., Hasanzadeh, M., & Ghafar-Zadeh, E. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116067 · Cited by 305
A comprehensive review of deep learning in colon cancer
Pacal, I., Karaboga, D., Basturk, A., Akay, B., & Nalbantoglu, U. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104003 · Cited by 283
Metadata
- Authors
- Schiffman, J. D., Fisher, P. G., & Gibbs, P.
- Venue
- American Society of Clinical Oncology Educational Book
- Published
- 2015-05
- Issue
- 35
- Pages
- 57-65
- ISSN
- 1548-8748 (ISSN-L)
- 1548-8756
- OpenAlex
- W1566274562
- Cited by
- 327
- References
- 72
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.